- A diagnosis of AML, not otherwise specified requires the presence of at least 20% of the specific leukaemia cells in the blood/bone marrow.
- The immunophenotyping and genetic information available in this AML group can help the haematologist diagnose the precise type of AML.
- Although immunophenotypes aren’t conclusive for making a diagnosis, they are useful to exclude other types of leukaemia in difficult cases.
- More distinct subtypes in the AML, not otherwise specified group are
- Acute megakaryoblastic leukaemia (AMKL)
- Acute myelomonocytic leukaemia (AMML)
- Details of these subtypes are available at shop.leukaemiacare.org.uk